Author: healthprofessionalradio

Dr. William Dale, director of the Center for Cancer and Aging and vice chair for academic affairs in the Department of Supportive Care Medicine at City of Hope, a cancer research and treatment organization, discusses the updated cancer and aging guideline released by the American Society of Clinical Oncology. A geriatric assessment is defined as an evaluation of an older adult’s physical and cognitive abilities, emotional health, co-existing medical conditions, medications, nutrition, and social circumstances. This assessment is suggested to help clinicians modify cancer treatment and improve patient’s quality of life. The update includes a new tool so that the largest demographic of cancer patients has an increased chance of receiving precision medicine and improved health outcomes. More information can be found at mycarg.org or you can ask Dr. Dale on Twitter @WilliamDale_MD.

Dr. Robert Phillips, MD, Executive Director of the Center for Professionalism and Value in Health Care, American Board of Family Medicine, and Professor of Family Medicine at Georgetown University and Virginia Commonwealth University discusses the American Board of Family Medicine’s new survey which highlights the importance of doctor-patient relationships in primary care and efforts to measure and support the improvements.

Dr. Marisa Cruz, MD, Chief Medical Officer at Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitoring and diagnostics, discusses her experience as a practicing clinician at UCSF, Empatica’s FDA-cleared Empatica Health Monitoring Platform, digital biomarkers, the company’s vision for remote patient monitoring and its use in decentralized clinical research.

Dr. Kristi Tough DeSapri, MD, owner of Bone & Body Women’s Health, a midlife women’s health medical practice discusses the need for women to understand their risk factors for osteoporosis and find strategies to maintain bone strength and reduce the risk for falls and fractures.

Dr. Svetlana Babajanyan, MD, Executive Medical Director of Medical Affairs for Oncology at Bayer U.S. Pharmaceuticals discusses new findings from three separate studies analyzing the safety & efficacy of Vitrakvi (larotrectinib) in pediatric and adult patients. These data were presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

Dr. Fahar Merchant, PhD, President and CEO of Medicenna Therapeutics, a clinical-stage immunotherapy company, discusses the company’s Superkine platform and other recent developments.

Dr. Erica P. Gunderson, ​PhD, MS, MPH, Senior research scientist at Kaiser Permanente Northern California Division of Research and a professor of Health Systems Science at Kaiser Permanente Bernard J. Tyson School of Medicine discusses being named the recipient of the 2022-2023 March of Dimes Agnes Higgins Award in Maternal-Fetal Nutrition. Her work has produced some of the field’s most important and astounding findings on pregnancy and breastfeeding’s links to diabetes and cardiovascular disease in young women. She received the award at the annual meeting of the Pediatric Academic Society (PAS).

Dr. Ilias Alevizos, DMD, PhD, Executive Medical Director, Clinical Development at Horizon Therapeutics discusses data from the Phase 2 trial results on dazodalibep for two Sjögren’s syndrome populations. This program is the only Sjögren’s Phase 2 trial to meet the primary endpoint in both patient populations.

Professor Moshe Szyf, Founder and CEO of HKG Epitherapeutics, discusses epigenetic research, the company’s novel tools for early detection of cancer and promoting healthy aging, recent data published on the ability of the company’s proprietary epiCervix test to detect cervical cancer in patients sooner and more.

Saad Harti, founder and CEO of Swiss-based biotech Legacy Healthcare discusses the company’s positive Phase 2/3 data and filing of their lead prescription botanical drug Coacillium for the treatment of an autoimmune condition, alopecia areata. He also talks about a recent survey which found that patients would prefer prescription botanical drugs to treat their chronic diseases.